SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1849 |
Sector | Life Science |
Employees | 8,300 |
Revenue | 58.5B USD (2023) |
Pfizer is a global pharmaceutical company that is involved in the discovery, development, manufacture, and marketing of a wide range of healthcare products, including medicines and vaccines. The company's portfolio includes treatments across a broad spectrum of areas such as oncology, cardiology, neurology, and infectious diseases, among others. Pfizer was founded in 1849 and is based in New York, New York.
DEAL STATS | # |
---|---|
Overall | 24 of 43 |
Sector (Life Science) | 21 of 39 |
Type (Add-on Acquisition) | 19 of 31 |
State (Illinois) | 1 of 1 |
Country (United States) | 19 of 31 |
Year (2015) | 2 of 3 |
Size (of disclosed) | 5 of 21 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2015-01-07 |
Redvax
Zurich, Switzerland Redvax is a Swiss, preclinical biopharmaceutical company based in Zurich. Redvax has produced a preclinical human cytomegalovirus (CMV) vaccine candidate, as well as intellectual property and a technology platform related to a second, undisclosed vaccine program. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2015-07-02 |
Pfizer - Ion Channel and Transporter Drug R&D
United States Pfizer - Ion Channel and Transporter Drug R&D platform is a provider of comprehensive services for ion channel and transporter drug discovery, combining Icagen's industry-leading scientific expertise and extensive portfolio of assays and cell lines with XRpro Sciences' proprietary, label-free X-ray fluorescence technology. |
Sell | - |